PRPH

$0.01-16.90%visit website

ProPhase Labs, Inc.

Market Cap

$91,996.08

Live price × SEC shares (Aug 17, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.02

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.0

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	883	784	1,169	1,011	3,847
Cost of revenue	1,006	537	874	785	3,202
Gross profit	(123)	247	295	226	645
Research & development	6.00	0.00
Total operating expenses	4,641	5,973	2,721	2,871	16,206
Operating income	(4,764)	(5,726)	(2,426)	(2,645)	(15,561)
Interest expense	1,549	4,258	651	791	7,249
Pretax income	(6,996)	(8,020)	(3,801)	(3,039)	(21,856)
Income tax	(157)	(622)	1,374	12	607
Net income	(6,839)	(7,398)	(5,175)	(3,051)	(22,463)
EPS (basic) ($)	(0.16)		(0.42)	(0.22)	—
EPS (diluted) ($)	(0.16)		(0.42)	(0.22)	—
Weighted avg. shares (basic)	41,541		12,317	14,016
Weighted avg. shares (diluted)	41,541		12,317	14,016

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 19, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

18 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Aug 6, 2026 accepted 9:00 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Feb 13, 2026 accepted 10:15 PM ET	8.01Other events	Document SEC ↗
Feb 13, 2026 accepted 10:15 PM ET	8.01Other events	Document SEC ↗
Jan 27, 2026 accepted 4:06 PM ET	8.01Other events	Document SEC ↗
Jan 23, 2026 accepted 10:20 PM ET	8.01Other events	Document SEC ↗
Jan 23, 2026 accepted 10:15 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Jan 9, 2026 accepted 10:15 PM ET	8.01Other events	Document SEC ↗
Jan 9, 2026 accepted 10:10 PM ET	5.02Officer / director change	Document SEC ↗
Jan 2, 2026 accepted 10:10 PM ET	3.01Delisting notice	Document SEC ↗
Dec 19, 2025 accepted 8:37 PM ET	8.01Other events	Document SEC ↗